Reply from authors: Vein graft biology and the risk of graft occlusion
AS Antonopoulos, A Kardos, C Antoniades - The Journal of Thoracic and …, 2020 - jtcvs.org
T saphenous vein graft (SVG) occlusion. The developed SAFINOUS risk score 2 is
composed of clinical, laboratory, and operative factors and predicts the risk for early SVG …
composed of clinical, laboratory, and operative factors and predicts the risk for early SVG …
[引用][C] Reply from authors: Vein graft biology and the risk of graft occlusion.
AS Antonopoulos, A Kardos… - The Journal of Thoracic …, 2020 - europepmc.org
This is a comment on" The no-touch saphenous vein should be considered in a risk score of
vein graft failure." J Thorac Cardiovasc Surg. 2020 Jul; 160 (1): e1-e2.
vein graft failure." J Thorac Cardiovasc Surg. 2020 Jul; 160 (1): e1-e2.
[引用][C] Reply from authors: Vein graft biology and the risk of graft occlusion
AS Antonopoulos, A Kardos… - The Journal of …, 2020 - pubmed.ncbi.nlm.nih.gov
Reply from authors: Vein graft biology and the risk of graft occlusion Reply from authors: Vein graft
biology and the risk of graft occlusion J Thorac Cardiovasc Surg. 2020 Jul;160(1):e2-e4. doi …
biology and the risk of graft occlusion J Thorac Cardiovasc Surg. 2020 Jul;160(1):e2-e4. doi …
[PDF][PDF] Adult: Coronary: Letters to the Editor
T Kopjar, H Gasparovic, B Biocina - researchgate.net
T saphenous vein graft (SVG) occlusion. The developed SAFINOUS risk score 2 is
composed of clinical, laboratory, and operative factors and predicts the risk for early SVG …
composed of clinical, laboratory, and operative factors and predicts the risk for early SVG …